|
Market Closed -
NYSE
21:00:03 02/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 337.84 USD | +2.12% |
|
+2.07% | +0.03% |
| 10-21 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| 10-21 | Baird Adjusts Price Target on Cencora to $375 From $373 | MT |
| Market Cap | 64.47B 57.56B 52.82B 48.05B 90.08B 6,103B 91.87B 631B 254B 3,221B 242B 237B 10,175B | P/E 2026 * |
17.9x | P/E 2027 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise Value | 71.89B 64.18B 58.9B 53.57B 100B 6,806B 102B 703B 284B 3,592B 270B 264B 11,346B | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.2x |
| Free-Float |
61.21% | Yield 2026 * |
0.7% | Yield 2027 * | 0.72% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
London S.E.
| 0HF3 | Delayed | |
|
Berne S.E.
| ABG | End-of-day quote | |
|
Wiener Boerse
| ABC | End-of-day quote | |
|
Tradegate
| ABG | Real-time | |
|
Boerse Muenchen
| ABG | Real-time | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Xetra
| ABG | Delayed | |
|
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | +2.12% | ||
| 1 week | +2.07% | ||
| Current month | +2.12% | ||
| 1 month | +9.06% | ||
| 3 months | +8.51% | ||
| 6 months | +11.13% | ||
| Current year | +0.03% |
| 1 week | 320.06 |  | 340.19 |
| 1 month | 307.87 | | 345.46 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 191.11 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.7 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 30/09/2024 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 28/06/2026 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 03/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 15/05/2013 |
Robert Mauch
BRD | Director/Board Member | 59 | 30/09/2024 |
D. Mark Durcan
CHM | Chairman | 64 | 30/09/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Other | Director | 275 | 0.0001% | ||
| 01/10/26 | Sell | Controller/Auditor | -986 | 0.0005% | ||
| 01/10/26 | Other | Director | 197 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.12% | +2.07% | +0.01% | +80.44% | 63.13B | |
| +3.73% | +6.23% | -10.89% | +15.95% | 184B | |
| +2.85% | +4.07% | +9.47% | +40.14% | 118B | |
| +5.12% | -0.11% | -13.88% | +12.78% | 111B | |
| +1.41% | +6.80% | -41.10% | +6.45% | 94.58B | |
| -5.48% | -5.08% | -1.24% | +63.86% | 55.66B | |
| +0.36% | -0.16% | +11.13% | -21.74% | 53.9B | |
| +21.85% | +19.85% | +6.69% | +69.88% | 43.42B | |
| +2.23% | +4.28% | +1.04% | -7.87% | 34.68B | |
| +3.00% | +8.75% | +45.59% | -9.95% | 30.69B | |
| Average | +3.72% | +1.91% | +0.68% | +24.99% | 78.91B | |
| Weighted average by Cap. | +3.41% | +2.44% | -5.14% | +24.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 301B 276B 251B 471B 31,907B 480B 3,298B 1,329B 16,841B 1,265B 1,238B 53,193B | 352B 314B 288B 262B 491B 33,294B 501B 3,441B 1,387B 17,573B 1,320B 1,292B 55,505B |
| Net income | 3.58B 3.2B 2.93B 2.67B 5B 339B 5.1B 35.03B 14.12B 179B 13.44B 13.15B 565B | 2.84B 2.54B 2.33B 2.12B 3.98B 269B 4.05B 27.84B 11.22B 142B 10.68B 10.45B 449B |
| Net Debt | 7.42B 6.62B 6.08B 5.53B 10.37B 702B 10.57B 72.59B 29.26B 371B 27.84B 27.25B 1,171B | 5.95B 5.31B 4.87B 4.43B 8.31B 563B 8.47B 58.19B 23.45B 297B 22.32B 21.84B 938B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | US$337.84 | +2.12% | 1,506,754 |
| 30/10/26 | US$330.84 | +0.09% | 1,347,722 |
| 29/10/26 | US$330.53 | +1.91% | 1,025,270 |
| 28/10/26 | US$324.35 | -0.31% | 1,076,740 |
| 27/10/26 | US$325.37 | -1.40% | 1,123,060 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
